共 50 条
- [47] Long-Term Safety and Efficacy of Certolizumab Pegol Therapy in Patients With Moderate to Severe Crohn's Disease: 5-Year Results [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S774 - S775
- [48] Efficacy and safety of certolizumab pegol in an unselected Crohn's disease population: long-term data of the FACTS III survey [J]. JOURNAL OF CROHNS & COLITIS, 2015, 9 : S335 - S335